284 related articles for article (PubMed ID: 19605741)
1. How to dose infliximab in rheumatoid arthritis: new data on a serious issue.
van Vollenhoven RF
Ann Rheum Dis; 2009 Aug; 68(8):1237-9. PubMed ID: 19605741
[No Abstract] [Full Text] [Related]
2. Increasing the infliximab dose in rheumatoid arthritis patients: a randomised, double blind study failed to confirm its efficacy.
Pavelka K; Jarosová K; Suchý D; Senolt L; Chroust K; Dusek L; Vencovský J
Ann Rheum Dis; 2009 Aug; 68(8):1285-9. PubMed ID: 19351624
[TBL] [Abstract][Full Text] [Related]
3. Use of rituximab for the treatment of rheumatoid arthritis: the Latin American context.
Soriano ER; Galarza-Maldonado C; Cardiel MH; Pons-Estel BA; Massardo L; Caballero-Uribe CV; Achurra-Castillo AF; Barile-Fabris LA; Chávez-Corrales J; Díaz-Coto JF; Esteva-Spinetti MH; Guibert-Toledano M; Palazuelos FI; Keiserman MW; Lomonte AV; Mota LM; Pineda Villaseñor C; Alarcón GS;
Rheumatology (Oxford); 2008 Jul; 47(7):1097-9. PubMed ID: 18463144
[No Abstract] [Full Text] [Related]
4. Increase in methotrexate dose in patients with rheumatoid arthritis who have an inadequate response to infliximab.
Ornetti P; Solau E; Gaudin P; Sibilia J; Berthelot JM; Puechal X; Tavernier C; Maillefert JF;
Ann Rheum Dis; 2005 Sep; 64(9):1379-80. PubMed ID: 16100349
[No Abstract] [Full Text] [Related]
5. Timing of DAS28 in infliximab therapy.
Armstrong DJ; Bruce IN
Rheumatology (Oxford); 2005 Sep; 44(9):1203-4; author reply 1204. PubMed ID: 15870143
[No Abstract] [Full Text] [Related]
6. [Experiences with infliximab in the treatment of active rheumatoid arthritis and spondyloarthropathy].
Dahlin J; Sørensen SF
Ugeskr Laeger; 2003 Nov; 165(48):4646-9. PubMed ID: 14677464
[No Abstract] [Full Text] [Related]
7. Observational cohort studies and well controlled clinical trials--we need them both!
Furst DE
J Rheumatol; 2004 Aug; 31(8):1476-7. PubMed ID: 15290723
[No Abstract] [Full Text] [Related]
8. Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies.
Teng YK; Tekstra J; Breedveld FC; Lafeber F; Bijlsma JW; van Laar JM
Ann Rheum Dis; 2009 Jun; 68(6):1075-7. PubMed ID: 19435725
[No Abstract] [Full Text] [Related]
9. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
Toki H; Momohara S; Tsukahara S; Ikari K
J Rheumatol; 2008 Sep; 35(9):1896-7; author reply 1897. PubMed ID: 18785300
[No Abstract] [Full Text] [Related]
10. Shortening infusion times for infliximab administration.
Buch MH; Bryer D; Lindsay S; Rees-Evans B; Fairclough A; Emery P
Rheumatology (Oxford); 2006 Apr; 45(4):485-6. PubMed ID: 16352636
[No Abstract] [Full Text] [Related]
11. Rituximab (Rituxan) for rheumatoid arthritis.
Med Lett Drugs Ther; 2006 Apr; 48(1233):34-5. PubMed ID: 16625143
[No Abstract] [Full Text] [Related]
12. Long-term treatment of rheumatoid arthritis with tumour necrosis factor alpha blockade: outcome of ceasing and restarting biologicals.
Buch MH; Marzo-Ortega H; Bingham SJ; Emery P
Rheumatology (Oxford); 2004 Feb; 43(2):243-4. PubMed ID: 14739466
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of infliximab for the treatment of psoriatic arthritis.
Ritchlin C
Nat Clin Pract Rheumatol; 2006 Jun; 2(6):300-1. PubMed ID: 16932707
[No Abstract] [Full Text] [Related]
14. Reactions to infliximab in patients with rheumatoid arthritis.
Sakellariou GT; Chatzigiannis I
J Rheumatol; 2005 Jul; 32(7):1411-2. PubMed ID: 15996088
[No Abstract] [Full Text] [Related]
15. Dose escalation of infliximab therapy in arthritis patients is related to diagnosis and concomitant methotrexate treatment: observational results from the South Swedish Arthritis Treatment Group register.
Kristensen LE; Geborek P; Saxne T
Rheumatology (Oxford); 2009 Mar; 48(3):243-5. PubMed ID: 19106164
[TBL] [Abstract][Full Text] [Related]
16. Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab.
Elkayam O; Hawkins PN; Lachmann H; Yaron M; Caspi D
Arthritis Rheum; 2002 Oct; 46(10):2571-3. PubMed ID: 12384913
[TBL] [Abstract][Full Text] [Related]
17. Is IV infliximab better than IV methylprednisolone for the treatment of patients with RA when methotrexate fails?
Smith MD
Ann Rheum Dis; 2005 Mar; 64(3):512; author reply 512. PubMed ID: 15708914
[No Abstract] [Full Text] [Related]
18. A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis.
van den Bemt BJ; Vos K; den Broeder AA; Blom M; Thurlings RM; Bartelds GM; Stapel SO; Barrera P; Tak PP; Nurmohamed MT; Wolbink GJ
Ann Rheum Dis; 2009 Aug; 68(8):1368-9. PubMed ID: 19605744
[No Abstract] [Full Text] [Related]
19. Improvement with rituximab in a patient with both rheumatoid arthritis and myasthenia gravis.
Kerkeni S; Marotte H; Miossec P
Muscle Nerve; 2008 Oct; 38(4):1343-5. PubMed ID: 18816604
[No Abstract] [Full Text] [Related]
20. Comparative multidatabase analysis of dosing patterns and infusion intervals for the first 12 infliximab infusions in patients with rheumatoid arthritis.
Bolge SC; Carter CT; Mueller CS; Bailey RA; Ingham MP
Clin Ther; 2012 Dec; 34(12):2286-92. PubMed ID: 23153660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
